Progress in optimizing antiplatelet therapy after percutaneous coronary intervention in the year of 2021.
10.3760/cma.j.cn112148-20211027-00919
- Author:
Ya Ling HAN
1
;
Yang LI
1
Author Information
1. Department of Cardiology, General Hospital of Northern Theater Command, Shenyang 110016, China.
- Publication Type:Journal Article
- MeSH:
Acute Coronary Syndrome/drug therapy*;
Drug Therapy, Combination;
Humans;
Percutaneous Coronary Intervention;
Platelet Aggregation Inhibitors/therapeutic use*;
Treatment Outcome
- From:
Chinese Journal of Cardiology
2021;49(12):1184-1186
- CountryChina
- Language:Chinese
